Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001104659-21-140230

Director acquired 100,000 shares (conversion)

  • Director returned 14,887 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BARASCH RICHARD A Director 2021-11-12 Conversion +100,000 100,000 D: show line 1 in the form
BARASCH RICHARD A Director 2021-11-12 Returned to the company −14,887 85,113 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BARASCH RICHARD A Director 2021-11-12 Conversion · Class B Common Stock −100,000 0 D: show line 3 in the form
Loading xslF345X03/tm2132979-16_4seq1.xml…